Arigen Pharmaceuticals, Inc.
Records under this name other than patents Arigen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Arigen Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,440,913 | Dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient Formerly held Lapsed on the fee record Ended Sep 13, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 13, 2020 | USPTO record |
| US 7,968,588 | Injectable formulation of antibiotic and solution for intravenous administration thereof Formerly held Lapsed on the fee record Ended Jun 28, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 28, 2019 | USPTO record |
| US 8,778,975 | Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion Formerly held Lapsed on the fee record Ended Jul 15, 2018 · USPTO record | Lapsed on the fee record | Ended Jul 15, 2018 | USPTO record |
| US 7,622,598 | Phenol derivatives and antitrypanosoma preventive/therapeutic agent comprising the same as active ingredient Lapsed on the fee record Ended Nov 24, 2017 · USPTO record | Lapsed on the fee record | Ended Nov 24, 2017 | USPTO record |
| US 7,618,950 | Method for treatment and prevention of herpes zoster by topical application Formerly held Lapsed on the fee record Ended Nov 17, 2017 · USPTO record | Lapsed on the fee record | Ended Nov 17, 2017 | USPTO record |
| US 7,495,011 | Anti-coronavirus drug Lapsed on the fee record Ended Feb 24, 2017 · USPTO record | Lapsed on the fee record | Ended Feb 24, 2017 | USPTO record |
| US 6,773,710 | Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis Lapsed on the fee record Ended Aug 10, 2016 · USPTO record | Lapsed on the fee record | Ended Aug 10, 2016 | USPTO record |
| US 8,076,302 | Pyrimidine nucleoside derivatives and salts thereof Formerly held Lapsed on the fee record Ended Dec 13, 2015 · USPTO record | Lapsed on the fee record | Ended Dec 13, 2015 | USPTO record |
| US 7,868,206 | Trihalomethionine derivative and pharmaceutical product containing the same Lapsed on the fee record Ended Jan 11, 2015 · USPTO record | Lapsed on the fee record | Ended Jan 11, 2015 | USPTO record |
| US 5,648,455 | Antibiotic WAP-8294A, method for preparing the same and antibacterial composition Formerly held Term ended Term ended no later than Jul 15, 2017 · Low confidence | Term ended | Term ended no later than Jul 15, 2017 | Low confidence |